Intra-Cellular Therapies, Inc.

ITCI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$306,948$147,767$148,615$92,365
Short-Term Investments$694,118$350,174$443,290$319,968
Receivables$166,500$114,018$75,189$20,156
Inventory$26,283$11,647$23,920$7,948
Other Curr. Assets$113,515$44,193$46,943$26,844
Total Curr. Assets$1,307,364$667,799$737,957$467,281
Property Plant & Equip (Net)$14,896$14,582$16,737$22,555
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$44,652$45,914$86$86
Total NC Assets$59,548$60,496$16,823$22,641
Other Assets$0$0$0$0
Total Assets$1,366,912$728,295$754,780$489,922
Liabilities
Payables$26,074$11,452$10,395$8,691
Short-Term Debt$4,233$3,612$4,567$6,732
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$175,397$108,481$68,274$37,933
Total Curr. Liab.$205,704$123,545$83,236$53,356
LT Debt$12,748$13,326$15,474$18,693,618
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0-$18,674,943
Total NC Liab.$12,748$13,326$15,474$18,675
Other Liabilities$0$0$0$0
Cap. Leases$0$16,938$20,041$25,407
Total Liabilities$218,452$136,871$98,710$72,031
Equity
Pref Stock$0$0$0$0
Common Stock$11$10$9$8
Retained Earnings-$1,691,836-$1,617,160-$1,477,486-$1,221,230
AOCI$191$104-$4,190-$364
Other Equity$2,840,094$2,208,470$2,137,737$1,639,476
Total Equity$1,148,460$591,424$656,070$417,891
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,366,912$728,295$754,780$489,922
Net Debt-$289,967-$130,829-$128,574$18,607,985
Intra-Cellular Therapies, Inc. (ITCI) Financial Statements & Key Stats | AlphaPilot